Genome Alberta
Overview
Genome Alberta is a not-for-profit corporation that initiates, funds, and manages genomics research and innovation projects across the health, agriculture, environment, and energy sectors in Alberta.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nanostics Inc. | Jun 2025 | Grant | Co-investor |
| ABAzyne BioScience Inc. | Jul 2026 | Accelerator | Co-investor |
| MHCombiotic Inc. | Mar 2026 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Genome Alberta based?
Genome Alberta is headquartered in Calgary, Alberta, Canada.
When was Genome Alberta founded?
Genome Alberta was founded in 2005.
How many portfolio companies does Genome Alberta have?
Genome Alberta has 3 portfolio companies in Caplight's dataset.
What are some companies in Genome Alberta's portfolio?
Portfolio companies visible on Caplight include Nanostics Inc., ABAzyne BioScience Inc., MHCombiotic Inc..
What was Genome Alberta's most recent investment shown here?
Genome Alberta's most recent investment in this portfolio sample was in ABAzyne BioScience Inc. in 2026.
What sectors does Genome Alberta focus on?
Genome Alberta focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Genome Alberta focus on?
Genome Alberta typically invests at the Early stage.
What is Genome Alberta's AUM?
Genome Alberta's assets under management are estimated between $441.7M and $441.7M.